Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-24-031107

Options or other derivatives

  • Chief Operating Officer acquired 152,345 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
BILINSKY IGOR Chief Operating Officer 2024-03-01 Grant or award · Restricted Stock Units +105,470 105,470 D: show line 1 in the form
BILINSKY IGOR Chief Operating Officer 2024-03-01 Grant or award · Restricted Stock Units +46,875 46,875 D: show line 2 in the form
Loading xslF345X05/tm248017-3_4seq1.xml…